Nigel Plummer PhD has his doctorate in microbial physiology from the University of Surrey, UK and began his career at Pfizer working on the development and manufacture of antibiotics.
This interest in disease control lead to the development in the 1980’s of his first probiotic product for the prevention of neonatal diarrhoea in young pigs and calves. This commitment to R&D has continued both in the academic sphere with his research group having now published more than 100 original scientific papers in the areas of the human microbiome, probiotics, omega-3 fatty acids and the potential for use of plant antimicrobials for the treatment of infectious disease. In addition, 12 full human RCT’s have been published on the impact of probiotics on many aspects of human physiology and pathology, and this investment in R&D is accelerating
Commercially, Nigel Plummer is CEO of Cultech, a specialist fully integrated, fully GMP approved manufacturer of probiotics, and supplies probiotic products to numerous retailer and proprietary brands globally.